ProPhase Labs Total Current Liabilities

ProPhase Labs (PRPH) currently reports a total current liabilities of $56M as of March 2026. That compares with $24M in the prior-year period — up 131.2% year over year. Use the charts on this page to explore ProPhase Labs's total current liabilities history and peer comparisons.

ProPhase Labs's total current liabilities increased from $24M to $56M — a 131.2% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ProPhase Labs reported $56M in total current liabilities as of March 2026. That compares with $24M in the prior-year period — up 131.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $56M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ProPhase Labs, and consider following PRPH for alerts when major investors trade the stock.

ProPhase Labs is classified in the Healthcare sector. On total current liabilities, it currently shows $56M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRPH with unrelated industries.